Clinical Trial Evaluating the Efficacy and Safety of Favipiravir in Moderate to Severe COVID-19 Patients

NCT04529499 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

353

Enrollment

INDUSTRY

Sponsor class

Stopped Study met pre-defined criteria for futility at interim analysis

Conditions

Covid19

Interventions

DRUG: AVIGAN
DRUG: Placebo Comparator

Sponsor

Dr. Reddy's Laboratories Limited